CAPTRUST Financial Advisors’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
Other funds holding LAB
LFCM
CAPTRUST Financial Advisors's LAB Position: Q3 2026 in Review
CAPTRUST Financial Advisors sold out of Standard BioTools (LAB) in Q3 2026, closing a stake of 28,742 shares — an estimated $23.6K sold.
CAPTRUST Financial Advisors first reported a position in LAB in Q1 2021 and held it in 11 quarters. The position peaked at $26K in Q2 2021. 104 funds tracked by Wall St. Rank hold LAB as of Q3 2026.
- CAPTRUST Financial Advisors reported no remaining Standard BioTools position as of Q3 2026 after selling out during the quarter.
- CAPTRUST Financial Advisors sold 28,742 Standard BioTools shares in Q3 2026, an estimated $23.6K.
- CAPTRUST Financial Advisors first reported a position in Standard BioTools in Q1 2021 and held it in 11 quarters.
- CAPTRUST Financial Advisors's Standard BioTools position peaked at $26K in Q2 2021.
- 104 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2026.
Based on CAPTRUST Financial Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.